You just read:

Surveyed Neurologists Report Significantly Higher Relapsing-Remitting Multiple Sclerosis Patient Shares for Gilenya and Tysabri, Compared With One Year Ago

News provided by

BioTrends Research Group

Dec 12, 2013, 10:00 ET